GCP
HCAT icon

GSA Capital Partners’s Health Catalyst HCAT Stock Holding History

GSA Capital Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,532
Closed -$44K – 1914
2026
Q1 		$44K Sell
34,532
-107,805
-76% -$203K ﹤0.01% 1613
2025
Q4 		$340K Buy
+142,337
New +$389K 0.03% 1100
2025
Q3 		– Sell
-108,383
Closed -$409K – 1837
2025
Q2 		$409K Buy
108,383
+15,812
+17% +$62.2K 0.03% 1052
2025
Q1 		$419K Buy
+92,571
New +$490K 0.04% 921
2024
Q4 		– Sell
-22,934
Closed -$187K – 1763
2024
Q3 		$187K Sell
22,934
-87,851
-79% -$635K 0.01% 1423
2024
Q2 		$708K Buy
110,785
+99,616
+892% +$639K 0.05% 745
2024
Q1 		$84K Sell
11,169
-28,685
-72% -$262K 0.01% 1503
2023
Q4 		$369K Buy
+39,854
New +$326K 0.03% 999
2023
Q1 		– Sell
-103,925
Closed -$1.1M – 1648
2022
Q4 		$1.1M Buy
+103,925
New +$1M 0.14% 173
2022
Q3 		– Sell
-93,315
Closed -$1.35M – 1666
2022
Q2 		$1.35M Buy
+93,315
New +$1.59M 0.2% 57

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's HCAT Position: Q2 2026 in Review

GSA Capital Partners sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 34,532 shares — an estimated $44K sold.

GSA Capital Partners first reported a position in HCAT in Q2 2022 and held it in 10 quarters. The position peaked at $1.35M in Q2 2022. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • GSA Capital Partners reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 34,532 Health Catalyst shares in Q2 2026, an estimated $44K.
  • GSA Capital Partners first reported a position in Health Catalyst in Q2 2022 and held it in 10 quarters.
  • GSA Capital Partners's Health Catalyst position peaked at $1.35M in Q2 2022.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.